Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India: Implications in achieving Target 3.2 of the Sustainable Development Goals

Birth Defects Research

Volumn 110, Issue 5, 2018, Pages 421-428

  Kancherla, Vijaya ^a   Oakley, Godfrey P ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

anencephaly; child mortality; India; mortality; spina bifida; sustainable development goals

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; CHILDHOOD MORTALITY; FOLIC ACID PREVENTABLE SPINA BIFIDA AND ANENCEPHALY; HUMAN; INDIA; INFANT MORTALITY; LIVE BIRTH; META ANALYSIS (TOPIC); MORTALITY RATE; NEURAL TUBE DEFECT; PREVALENCE; SOCIOECONOMICS; SPINAL DYSRAPHISM; EPIDEMIOLOGY; FEMALE; INFANT; MALE; MORTALITY; NEWBORN; PRESCHOOL CHILD;

ANENCEPHALY; CHILD MORTALITY; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HUMANS; INDIA; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; SPINAL DYSRAPHISM;

EID: 85036566627     PISSN: None     EISSN: 24721727     Source Type: Journal    
DOI: 10.1002/bdr2.1175     Document Type: Article

References (32)

1. Ahrens, K., Yazdy, M. M., Mitchell, A. A., & Werler, M. M. (2011). Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology, 22, 731–737.
2. Allagh, K. P., Shamanna, B. R., Murthy, G. V., Ness, A. R., Doyle, P., Neogi, S. B., & Pant, H. B.; Wellcome Trust-PHFI Folic Acid project team. (2015). Birth prevalence of neural tube defects and orofacial clefts in India: A systematic review and meta-analysis. PLoS ONE, 10(3), e0118961.
3. Arth, A., Kancherla, V., Pachón, H., Zimmerman, S., Johnson, Q., & Oakley, G. P., Jr. (2016). A 2015 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Research Part A Clinical and Molecular Teratology, 106(7), 520–529.
4. Atta, C. A., Fiest, K. M., Frolkis, A. D., Jette, N., Pringsheim, T., St Germaine-Smith, C., … Metcalfe, A. (2016). Global birth prevalence of spina bifida by folic acid fortification status: A systematic review and meta-analysis. American Journal of Public Health, 106(1), e24–e34.
5. Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H. … Correa, A. (1999). Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. New England Journal of Medicine, 341(20), 1485–1490.
6. Bhide, P., Sagoo, G. S., Moorthie, S., Burton, H., & Kar, A. (2013). Systematic review of birth prevalence of neural tube defects in India. Birth Defects and Research Part A Clinical and Molecular Teratology, 97(7), 437–443.
7. Blencowe, H., Cousens, S., Jassir, F. B., Say, L., Chou, D., Mathers, C. … Lawn, J. E.; Lancet Stillbirth Epidemiology Investigator Group. (2016). National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: A systematic analysis. Lancet Global Health, 4(2), e98–e108.
8. Castillo-Lancellotti, C., Tur, J. A., & Uauy, R. (2013). Impact of folic acid fortification of flour on neural tube defects: A systematic review. Public Health Nutrition, 16, 901–911.
9. Christianson, A. L., Howson, C. P., & Modell, B. (2006). Global report on birth defects: The hidden toll of dying and disabled children. White Plains (NY): March of Dimes Birth Defects Foundation.
10. Crider, K. S., Devine, O., Hao, L., Dowling, N. F., Li, S., Molloy, A. M., … Berry, R. J. (2014). Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ, 349(29), g4554.
11. Darmstadt, G. L., Howson, C. P., Walraven, G., Armstrong, R. W., Blencowe, H. K., Christianson, A. L. … Walani, S. R.; Participant Working Group of the Dar es Salaam Seventh International Conference on Birth Defects and Disabilities in the Developing World. (2016). Prevention of congenital disorders and care of affected children: A consensus statement. JAMA Pediatrics, 170(8), 790–793.
12. De Wals, P., Tairou, F., Van Allen, M. I., Uh, S. H., Lowry, R. B., Sibbald, B. … Niyonsenga, T. (2007). Reduction in neural-tube defects after folic acid fortification in Canada. New England Journal of Medicine, 357, 135–142.
13. Grosse, S. D., Berry, R. J., Tilford, J. M., Kucik, J. E., & Waitzman, N. J. (2016). Retrospective assessment of cost savings from prevention. Folic acid fortification and spina bifida in the U.S. American Journal of Preventive Medicine, 50(5 Suppl 1), S74–S80.
14. Elwood, J. H. (1970). Anencephalus in Belfast: Incidence and secular and seasonal variations, 1950-66. British Journal of Preventive & Social Medicine, 24(2), 78–88.
15. Elwood, J. H., & Nevin, N. C. (1973). Anencephalus and spina bifida in Belfast (1964–1968). Ulster Medical Journal, 42(2), 213–222.
16. Lawn, J. E., Blencowe, H., Pattinson, R., Cousens, S., Kumar, R., Ibiebele, I., … Stanton, C.; Lancet's Stillbirths Series steering committee. (2011). Stillbirths: Where? When? Why? How to make the data count? Lancet, 377, 1448–1463.
17. MacMahon, B., & Yen, S. (1971). Unrecognised epidemic of anencephaly and spina bifida. Lancet, 1(7688), 31–33.
18. Moore, C. A., Li, S., Li, Z., Hong, S. X., Gu, H. Q., Berry, R. J., … Erickson, J. D. (1997). Elevated rates of severe neural tube defects in a high-prevalence area in northern China. American Journal of Medical Genetics, 73(2), 113–118.
19. Mosley, B. S., Cleves, M. A., Siega-Riz, A. M., Shaw, G. M., Canfield, M. A., Waller, D. K. … Hobbs, C. A.; National Birth Defects Prevention Study. (2009). Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. American Journal of Epidemiology, 169, 9–17.
20. MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet, 338(8760), 131–137.
21. Murray, C. J. L. (2015). Shifting to sustainable developmental goals: Implications for global health. New England Journal of Medicine, 373(15), 1390–1393.
22. Oakeshott, P., Hunt, G. M., Poulton, A., & Reid, F. (2010). Expectation of life and unexpected death in open spina bifida: A 40-year complete, non-selective, longitudinal cohort study. Developmental Medicine & Child Neurology, 52(8), 749–753.
23. Oakley, G. P. Jr. (2009). The scientific basis for eliminating folic acid-preventable spina bifida: A modern miracle from epidemiology. Annals of Epidemiology, 19(4), 226–230.
24. Shurtleff, D. B., Luthy, D. A., Nyberg, D. A., Benedetti, T. J., & Mack, L. A. (1994). Meningomyelocele: Management in utero and post natum. Ciba Foundation Symposium, 181, 270–280.
25. Sustainable Developmental Goals. (2015). Sustainable Development Goals. Available at: https://sustainabledevelopment.un.org/sdgs. Accessed May 3, 2017
26. Sutton, M., Daly, L. E., & Kirke, P. N. (2008). Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects and Research Part A Clinical and Molecular Teratology, 82(10), 701–709.
27. United Nations. (2015). The United National Inter-Agency Group for Child Mortality Estimation (IGME)—Levels and Trends in Child Mortality Report, 2015. Available at: http://www.childmortality.org/files_v20/download/igme%20report%202015%20child%20mortality%20final.pdf. Accessed May 1, 2017
28. Wang, Y., Hu, J., Druschel, C. M., & Kirby, R. S. (2011). Twenty-five-year survival of children with birth defects in New York State: A population-based study. Birth Defects Research Part A Clinical and Molecular Teratology, 91(12), 995–1003.
29. Williams, J., Mai, C. T., Mulinare, J., Isenburg, J., Flood, T. J., Ethen, M. … Kirby, R. S. (2015). Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. Morbidity and Mortality Weekly Report, 64(1), 1–5.
30. World Health Organization. (2004). The Atlas of Country Resources for Neurological Disorders, WHO and the World Federation of Neurology, 2004. Available at: http://www.who.int/mental_health/neurology/neurogy_atlas_lr.pdf?ua=1; Accessed June 11, 2017
31. You, D., Hug, L., Ejdemyr, S., Idele, P., Hogan, D., Mathers, C. … Alkema, L. (2015). Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: A systematic analysis by the UN Inter-agency Group for Child Mortality Estimation. Lancet, 386(10010), 2275–2286.
32. World Health Organization. (2015). Neonatal-perinatal database and birth defects surveillance. Report of the regional review meeting. Available at: http://www.searo.who.int/entity/child_adolescent/documents/sea-cah-23/en/ Accessed June 11, 2017